ScandiDos ABOSTO:SDOS +1.20%48 PS Ratio is 0.88 as of Jul. 04, 2026, which is 55% below its 10-year median of 1.94. GuruFocus rates OSTO:SDOS with a GF Score™ of 48/100 and a GF Value™ of kr1.15 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, ScandiDos AB ranks better than 83.48% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, ScandiDos AB's share price is kr0.84.
ScandiDos AB's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 was kr0.96. Hence, ScandiDos AB's PS Ratio for today is 0.88.
Good Sign:
ScandiDos AB stock PS Ratio (=0.89) is close to 10-year low of 0.88.
The historical rank and industry rank for ScandiDos AB's PS Ratio or its related term are showing as below:
OSTO:SDOS'
s PS Ratio Range Over the Past 10 Years
Min: 0.88 Med: 1.94 Max: 5.8
Current: 0.88
During the past 13 years, ScandiDos AB's highest PS Ratio was 5.80. The lowest was 0.88. And the median was 1.94.
OSTO:SDOS's PS Ratio is ranked better than 83.48% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.94
vs OSTO:SDOS: 0.88
ScandiDos AB revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of ScandiDos AB was -12.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -11.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -6.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -5.60% per year.
During the past 13 years, ScandiDos AB's highest 3-Year average Revenue per Share Growth Rate was 9.00% per year. The lowest was -54.30% per year. And the median was -8.50% per year.
Back to Basics: PS Ratio
ScandiDos AB (OSTO:SDOS) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
ScandiDos AB PS Ratio Related Terms
ScandiDos AB PS Ratio Historical Data
* Premium members only.
The historical data trend for ScandiDos AB's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, ScandiDos AB's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ScandiDos AB PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ScandiDos AB's PS Ratio distribution charts can be found below:
* The bar in red indicates where ScandiDos AB's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
ScandiDos AB's PS Ratio for today is calculated as
ScandiDos AB's Share Price of today is kr0.84. ScandiDos AB's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.96.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
ScandiDos AB (OSTO:SDOS) has a PS Ratio of 0.88 as of Jul. 04, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on ScandiDos AB and its competitors. This is 55% below median its historical median of 1.94. Over the past decade, ScandiDos AB's PS Ratio has ranged from 0.88 to 5.80. According to the industry distribution chart, ScandiDos AB ranks #133 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 16.5%.
Is ScandiDos AB's PS Ratio too high?
ScandiDos AB's current PS Ratio of 0.88 is 55% below median its 10-year median of 1.94. Over the past 10 years, this metric has ranged from a low of 0.88 to a high of 5.80. The Medical Devices & Instruments industry median PS Ratio is 2.94. ScandiDos AB's value of 0.88 is 70.1% below this industry median. Based on the distribution chart, ScandiDos AB ranks #133 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, ScandiDos AB has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ScandiDos AB's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ScandiDos AB ranks #133 out of 805 companies for PS Ratio. This places ScandiDos AB in the top 17% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.94. ScandiDos AB's value of 0.88 is 70.1% below this benchmark. Historically, ScandiDos AB's own PS Ratio has ranged from 0.88 to 5.80 over the past decade. While the company's 10-year median is 1.94 vs. the industry median of 2.94, ScandiDos AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ScandiDos AB's current PS Ratio of 0.88 is 70.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on ScandiDos AB and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ScandiDos AB's current PS Ratio is 0.88, which is 55% below median its own 10-year median of 1.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ScandiDos AB stock overvalued right now?
Based on GuruFocus' analysis, ScandiDos AB (OSTO:SDOS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr1.15, compared to a current price of kr0.84 — trading 27% below its estimated fair value. The current PS Ratio is 0.88, which is 55% below median its 10-year median of 1.94 and 70.1% below the Medical Devices & Instruments industry median of 2.94. ScandiDos AB's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For ScandiDos AB (OSTO:SDOS), the current PS Ratio is 0.88 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ScandiDos AB (OSTO:SDOS) Overvalued in 2026?
Based on GuruFocus' analysis, ScandiDos AB stock appears to be undervalued.
The current stock price of kr0.84 is trading 27% below its estimated GF Value™ of kr1.15.
GuruFocus considers ScandiDos AB to be Modestly Undervalued.
Key valuation signals for OSTO:SDOS:
PS Ratio: 0.88 (55% below median its 10-year median of 1.94)
GF Value™: kr1.15 vs. price of kr0.84 (27% below fair value)
Industry Position: 70.1% below the Medical Devices & Instruments median (#133 of 805)
No single metric tells the full story. See the OSTO:SDOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ScandiDos AB is engaged in providing radiation therapy for cancer. Its product, Delta4 Phantom+, and its various hardware and software options are at the heart of everything ScandiDos does, from product development and production to marketing, sales, and customer support. With Delta4 HexaMotion ScandiDos has successfully developed a motion platform that recreates the movement of the tumor in six dimensions and independently simulates the patient's breathing movement.
48GF Score
Get the complete analysis for OSTO:SDOS
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SDOS has been successfully added to your 
